Current Ratio of Kalaris Therapeutics, Inc. from 31 Mar 2021 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Kalaris Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 31 Mar 2021 to 30 Sep 2025.
  • Kalaris Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 603%, a 59% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Kalaris Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 603% -859% -59% 30 Sep 2025
Q2 2025 780% -171% -18% 30 Jun 2025
Q1 2025 1003% +198% +25% 31 Mar 2025
Q4 2024 1098% +351% +47% 31 Dec 2024
Q3 2024 1461% +639% +78% 30 Sep 2024
Q2 2024 950% -24% -2.5% 30 Jun 2024
Q1 2024 805% -182% -18% 31 Mar 2024
Q4 2023 746% -307% -29% 31 Dec 2023
Q3 2023 822% -97% -11% 30 Sep 2023
Q2 2023 975% +77% +8.5% 30 Jun 2023
Q1 2023 987% -57% -5.4% 31 Mar 2023
Q4 2022 1053% -159% -13% 31 Dec 2022
Q3 2022 919% -868% -49% 30 Sep 2022
Q2 2022 898% -1361% -60% 30 Jun 2022
Q1 2022 1043% -1330% -56% 31 Mar 2022
Q4 2021 1212% 31 Dec 2021
Q3 2021 1787% 30 Sep 2021
Q2 2021 2259% 30 Jun 2021
Q1 2021 2374% 31 Mar 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.